| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system
|
Morimont, Laure
|
|
|
6 |
3 |
p.
|
article
|
| 2 |
Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months
|
Montague, Samantha J.
|
|
|
6 |
3 |
p.
|
article
|
| 3 |
Clustering extent‐dependent differential signaling by CLEC‐2 receptors in platelets
|
Dangelmaier, Carol
|
|
|
6 |
3 |
p.
|
article
|
| 4 |
Coagulation factor inhibitors in COVID‐19: From SARS‐CoV‐2 vaccination to infection
|
Jacobs, Jeremy W.
|
|
|
6 |
3 |
p.
|
article
|
| 5 |
Corrigendum
|
|
|
|
6 |
3 |
p.
|
article
|
| 6 |
Corrigendum
|
|
|
|
6 |
3 |
p.
|
article
|
| 7 |
Factor XIII is a newly identified binding partner for platelet collagen receptor GPVI‐dimer—An interaction that may modulate fibrin crosslinking
|
Moroi, Masaaki
|
|
|
6 |
3 |
p.
|
article
|
| 8 |
First do no harm
|
Huisman, Menno V.
|
|
|
6 |
3 |
p.
|
article
|
| 9 |
Impact of novel hemophilia therapies around the world
|
Ozelo, Margareth C.
|
|
|
6 |
3 |
p.
|
article
|
| 10 |
Issue Information
|
|
|
|
6 |
3 |
p.
|
article
|
| 11 |
Optimization of DOAC management services in a centralized anticoagulation clinic
|
Sylvester, Katelyn W.
|
|
|
6 |
3 |
p.
|
article
|
| 12 |
Platelet‐leukocyte interactions in COVID‐19: Contributions to hypercoagulability, inflammation, and disease severity
|
Hottz, Eugenio D.
|
|
|
6 |
3 |
p.
|
article
|
| 13 |
Platelets in the neonate: Not just a small adult
|
Davenport, Patricia
|
|
|
6 |
3 |
p.
|
article
|
| 14 |
Protease‐activated receptor antagonists prevent thrombosis when dual antiplatelet therapy is insufficient in an occlusive thrombosis microfluidic model
|
Berry, Jess
|
|
|
6 |
3 |
p.
|
article
|
| 15 |
Proteomics in thrombosis research
|
Edfors, Fredrik
|
|
|
6 |
3 |
p.
|
article
|
| 16 |
Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
|
Brinkman, Herm Jan M.
|
|
|
6 |
3 |
p.
|
article
|
| 17 |
Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England
|
Higgins, Hannah
|
|
|
6 |
3 |
p.
|
article
|
| 18 |
Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use
|
Wilkins, Cy R.
|
|
|
6 |
3 |
p.
|
article
|
| 19 |
Rotational thromboelastometry in critical phase of dengue infection: Association with bleeding
|
Wickramasinghe, Wasanthi
|
|
|
6 |
3 |
p.
|
article
|
| 20 |
Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey
|
Wilson, Hope P.
|
|
|
6 |
3 |
p.
|
article
|
| 21 |
Sialic acid and platelet count regulation: Implications in immune thrombocytopenia
|
Lee‐Sundlov, Melissa M.
|
|
|
6 |
3 |
p.
|
article
|
| 22 |
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study
|
Matino, Davide
|
|
|
6 |
3 |
p.
|
article
|
| 23 |
The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma
|
Siriez, Romain
|
|
|
6 |
3 |
p.
|
article
|
| 24 |
Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing
|
Engelen, Matthias M.
|
|
|
6 |
3 |
p.
|
article
|
| 25 |
Thrombotic microangiopathies: An illustrated review
|
Abou‐Ismail, Mouhamed Yazan
|
|
|
6 |
3 |
p.
|
article
|
Journal description